SCHEMBL27645263

SCHEMBL27645263

CCCCCOCCCCCc1sccc1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HTT P42858 1/20 0.37
MAPT P10636 1/20 0.37
ALDH1A1 P00352 2/20 0.35
CYP3A4 P08684 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
CASP1 P29466 1/20 0.35
SLCO1B3 Q9NPD5 1/20 0.35
SLCO1B1 Q9Y6L6 1/20 0.35
HTR2A P28223 1/20 0.35
KCNH2 Q12809 2/20 0.35
TP53 P04637 1/20 0.34
HSP90AA1 P07900 1/20 0.34
G6PD P11413 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27666384 0.88 HTR2A (0.38) ALDH1A1CYP3A4LMNAHTR2AKCNH2
SCHEMBL21158801 0.83 CASP3 (0.38) KMT2AHTTMAPTALDH1A1SMN1; SMN2
SCHEMBL25547088 0.75
SCHEMBL5544374 0.75 LTB4R (0.34)
SCHEMBL2095897 0.73 LTB4R (0.35)
SCHEMBL31094648 0.73 LTB4R (0.35)
SCHEMBL27644613 0.71 ALDH1A1 (0.51) THRBMEN1KMT2AHTTMAPT
SCHEMBL2096667 0.71 SLC6A3 (0.36)
SCHEMBL15648187 0.71 LTB4R (0.49) MEN1KMT2AHTTMAPTCYP3A4
SCHEMBL15152496 0.71 LTB4R (0.49) MEN1KMT2AHTTMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed